Commercialization Transition Plan definition

Commercialization Transition Plan means the Commercialization Transition Plan agreed by the Parties, as attached hereto in
Sample 1
Commercialization Transition Plan. 7.1.2 “Committee” 3.3.1
Sample 1
Commercialization Transition Plan means the Commercialization Transition Plan agreed by the Parties, as attached hereto in Schedule ‎4.4(a).
Sample 1

Examples of Commercialization Transition Plan in a sentence

  • If the Alliance Managers do not agree as to whether the activities under the Commercialization Transition Plan have been completed, the matter shall be resolved in accordance with Section 12.1.

  • With respect to any Product sold by Scynexis under a NDA in accordance with the Commercialization Transition Plan following the Effective Date, GSK shall reimburse Scynexis for all costs and expenses related to any recall, suspension, removal or other market withdrawal.

  • The Commercialization Transition Plan may not be modified or amended without the written agreement of representatives of both Parties with responsibility for implementation of the Commercialization Transition Plan.

  • During the period from the Restated Effective Date until the completion of the transfer of Commercialization activities from ARIAD to MERCK, ARIAD and MERCK shall each exercise Commercially Reasonable Efforts to expeditiously perform all activities set forth in the Commercialization Transition Plan attached hereto as Schedule 3 in accordance to the dates referenced in Schedule 3.

  • The Commercialization Transition Plan shall include **, and also include the estimate of all costs and expenses expected to be incurred in implementing the Commercialization Transition Plan, a copy of which is attached as Exhibit 7.1.

  • On the other hand, Kasumi-1/ Ii-siRNA blasts exhibited strongly reduced levels of extracellular DR.

  • Within thirty (30) days following March 31, 2010 and each month until completion of the Development Transition Plan, Manufacturing Transition Plan, and Commercialization Transition Plan, and the end of each subsequent Calendar Quarter thereafter during the Term, ARIAD shall submit to MERCK a written report setting forth in reasonable detail all Development Costs and Commercialization Costs incurred for activities performed by or on behalf of ARIAD over such period applicable to Products.

  • Exhibit 4.3B RLS Horizant Approval Letter Exhibit 4.4 Commercialization Transition Plan Exhibit 4.6 Manufacturing Technology Transfer Plan Exhibit 4.9 Safety Data Exchange Transfer Plan Exhibit 8.3 Form of Press Releases * CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, IS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 24B-2 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED.

  • Scynexis shall make Scynexis Personnel reasonably available to accomplish the activities set forth in such Commercialization Transition Plan, provided Scynexis shall have no obligation to retain or employ any Scynexis Personnel to fulfill this obligation.

  • The Parties shall use Commercially Reasonable Efforts to execute all activities in the Commercialization Transition Plan.


More Definitions of Commercialization Transition Plan

Commercialization Transition Plan means the plan for transition of Commercialization responsibilities from ARIAD to MERCK set forth in Schedule 3.
Sample 1
Commercialization Transition Plan shall have the meaning set forth in Section 4.4(a) of this Termination Agreement.
Sample 1

Related to Commercialization Transition Plan

  • Commercialization Plan has the meaning set forth in Section 6.2.

  • Development Plan has the meaning set forth in Section 3.2.

  • Development Plans means a coherent set of operations defined and financed exclusively by the OCTs in the framework of their own policies and strategies of development, and those agreed upon between an OCT and the Member State to which it is linked;

  • Transition Plan means a transition plan, acceptable to the LHIN that indicates how the needs of the HSP’s clients will be met following the termination of this Agreement and how the transition of the clients to new service providers will be effected in a timely manner; and

  • Commercialization or “Commercialize” means activities directed to marketing, promoting, research and development as required, manufacturing for sale, offering for sale, distributing, importing or selling a product, including sub-licensing or sub-contracting of these activities.

  • Development Activities means those activities which are normally undertaken for the development, construction, repair, renovation, rehabilitation or conversion of buildings for residential purposes, including the acquisition of property;

  • Initial Development Plan has the meaning set forth in Section 3.2(b).

  • Joint Commercialization Committee or “JCC” has the meaning set forth in Section 3.4 (Joint Commercialization Committee).

  • Development Program means the implementation of the development plan.

  • Commercial Development Plan means the written commercialization plan attached as Appendix E.

  • Project Implementation Plan means the detail plan submitted by the Developer with regard to development of Project Facilities and its operation and management thereof in accordance with this Agreement and to be appended as Schedule 9 to this Agreement.

  • Marketing Plan has the meaning set forth in Section 4.3(a).

  • Global Development Plan has the meaning set forth in Section 3.1.

  • Integrated Development Plan means a plan formulated and approved as envisaged in Section 25 of the Municipal Systems Act 2000, as amended.

  • Clinical Study means a Phase I Study, Phase II Study, Phase III Study, as applicable.

  • Research Plan shall have the meaning set forth in Section 2.1.

  • Clinical Trials means a controlled study in humans of the safety or efficacy of a Product, and includes, without limitation, such clinical trials as are designed to support expanded labeling or to satisfy the requirements of an Agency in connection with any Product Approval and any other human study used in research and Development of a Product.

  • Clinical Studies means human clinical trials for a Licensed Product and any other tests and studies for a Licensed Product in human subjects.

  • Phase I Clinical Study means a human clinical study of a product, the principal purpose of which is a preliminary determination of safety in healthy individuals or patients, as described in 21 C.F.R. 312.21(a).

  • Collaboration Product means a pharmaceutical product containing or comprising Compound in any dosage form alone, or in combination with, one or more other pharmaceutically active ingredients, and any and all Improvements thereto.

  • site development plan means a dimensioned plan drawn to scale that indicates details of the proposed land development, including the site layout, positioning of buildings and structures, property access, building designs and landscaping;

  • Medical Affairs Activities means, with respect to any country or other jurisdiction in the Territory, the coordination of medical information requests and field based medical scientific liaisons with respect to Licensed Compounds or Licensed Products, including activities of medical scientific liaisons and the provision of medical information services with respect to a Licensed Compound or Licensed Product.

  • Collaboration Agreement has the meaning set forth in the Recitals.

  • Clinical Supply Agreement has the meaning set forth in Section 4.2.

  • Development Milestone is defined in Section 5.3.

  • Collaboration Target means the Initial Collaboration Targets set forth on Exhibit F and any Additional Target or Substitute Target that is selected in accordance with Section 3.3 of this Agreement.